BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7963907)

  • 1. Activity of two doses of rifampin against Mycobacterium leprae.
    Husser JA; Traore I; Daumerie D
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
    Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
    Gelber RH; Humphres RC; Fieldsteel AH
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
    Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; Léoture A; Grosset JH; Sansarricq H
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
    Jamet P; Ji B
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy.
    Pardillo FE; Burgos J; Fajardo TT; Dela Crux E; Abalos RM; Paredes RM; Andaya CE; Gelber RH
    Lepr Rev; 2009 Jun; 80(2):205-9. PubMed ID: 19743625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.
    Grosset JH; Guelpa-Lauras CC; Bobin P; Brucker G; Cartel JL; Constant-Desportes M; Flageul B; Frédéric M; Guillaume JC; Millan J
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):607-14. PubMed ID: 2674301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
    Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term trial of clofazimine in previously untreated lepromatous leprosy.
    Jamet P; Traore I; Husser JA; Ji B
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):542-8. PubMed ID: 1299709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
    Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
    Ji B; Perani EG; Petinon C; Grosset JH
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
    N'Deli L; Guelpa-Lauras CC; Perani EG; Grosset JH
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):12-8. PubMed ID: 2181041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
    Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
    Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.